Recent advances in the genetics of schizophrenia

Cellular and Molecular Life Sciences

Volumn 59, Issue 2, 2002, Pages 331-348

  Waterworth, D M ^a   Bassett, A S ^b   Brzustowicz, L M ^a,c,d  

^a RUTGERS UNIVERSITY   (United States)

^b UNIVERSITY OF TORONTO   (Canada)

^c RUTGERS NEW JERSEY MEDICAL SCHOOL   (United States)

^d RUTGERS ROBERT WOOD JOHNSON MEDICAL SCHOOL   (United States)

Author keywords

Association; Endophenotype; Epidemiology; Linkage; PANSS

Indexed keywords

GENE MAPPING; GENETIC LINKAGE; GENETIC SUSCEPTIBILITY; HUMAN GENOME; LINKAGE ANALYSIS; PHARMACOGENETICS; PHENOTYPE; REVIEW; SCHIZOPHRENIA;

CYTOCHROME P-450 ENZYME SYSTEM; ENVIRONMENT; GENETIC PREDISPOSITION TO DISEASE; HUMANS; LINKAGE (GENETICS); RECEPTORS, DOPAMINE; RECEPTORS, SEROTONIN; SCHIZOPHRENIA;

EID: 0036179981     PISSN: 1420682X     EISSN: None     Source Type: Journal    
DOI: 10.1007/s00018-002-8426-6     Document Type: Review

References (150)

1. Symptoms, subtype, and suicidality in patients with schizophrenia spectrum disorders
2. Twin concordance for DSM-III schizophrenia. Scrutinizing the validity of the definition
3. Positive and negative symptoms in families with schizophrenia
4. The positive and negative symptom scale (PANSS) for schizophrenia
5. Structure and course of positive and negative symptoms in schizophrenia
6. Psychopathology of schizophrenia: Initial validation of a 5-factor model
7. Five-component model of schizophrenia: Assessing the factorial invariance of the positive and negative syndrome scale
8. Epidemiology of schizophrenia: The global burden of disease and disability
9. Gender and the course of schizophrenia: Differences in treated outcomes
10. Twin studies of schizophrenia: From bow-and-arrow concordances to Star Wars Mx and functional genomics
11. Confirming unexpressed genotypes for schizophrenia: Risks in the offspring of Fischer's Danish identical and fraternal discordant twins
12. Adoption studies of schizophrenia
13. Linkage strategies for genetically complex traits. I. Multilocus models
14. Eye tracking and schizophrenia: A selective review
15. Linkage of a neurophysiological deficit in schizophrenia to a chromosome 15 locus
16. The genetic epidemiology of schizophrenia and of schizophrenia spectrum disorders
17. Relative risk of attention deficits in siblings of patients with schizophrenia
18. Cognitive and behavioral precursors of schizophrenia
19. Impaired attention as an endotype for molecular genetic studies of schizophrenia
20. Obstetric complications and age at onset in schizophrenia: An international collaborative meta-analysis of individual patient data
21. Schizophrenia and complications of pregnancy and labor: An individual patient data meta-analysis
22. Association of schizophrenia with low maternal body mass index, small size at birth, and thinness during childhood
23. Labour and delivery complications and schizophrenia: Case-control study using contemporaneous labour ward records
24. Obstetric complications and schizophrenia: Two case-control studies based on structured obstetric records
25. Seasonality of birth in schizophrenia: The effect of regional population density
26. Seasonality of births in schizophrenia and bipolar disorder: A review of the literature
27. Seasonality and infectious disease in schizophrenia: The birth hypothesis revisited
28. Chromosomal abnormalities and schizophrenia
29. Identifying a series of candidate genes for mania and psychosis: A convergent functional genomics approach
30. Molecular characterization of schizophrenia viewed by microarray analysis of gene expression in pre-frontal cortex
31. Genetic dissection of complex traits: Guidelines for interpreting and reporting linkage results
32. Significance levels in complex inheritance
33. Methods of linkage analysis - And the assumptions underlying them
34. Parametric and nonparametric linkage analysis: A unified multipoint approach
35. Problems in the definition, interpretation, and evaluation of genetic heterogeneity
36. Direct power comparisons between simple LOD scores and NPL scores for linkage analysis in complex diseases
37. The power to detect linkage in complex disease by means of simple LOD-score analyses
38. Genomewide scan of multiple sclerosis in Finnish multiplex families
39. Complete multipoint sibpair analysis of qualitative and quantitative traits
40. Further evidence for the increased power of LOD scores compared with nonparametric methods
41. Trade-off between false positives and false negatives in the linkage analysis of complex traits
42. Genetic insights into schizophrenia
43. Genomic scan for genes predisposing to schizophrenia
44. Genome scan of schizophrenia
45. A genome-wide search for schizophrenia susceptibility genes
46. A two-stage genome scan for schizophrenia susceptibility genes in 196 affected sibling pairs
47. Location of a major susceptibility locus for familial schizophrenia on chromosome 1q21-q22
48. Use of unlinked genetic markers to detect population stratification in association studies
49. The NOTCH4 locus is associated with susceptibility to schizophrenia
50. Haplotype transmission disequilibrium and evidence for linkage of the CHRNA7 gene region to schizophrenia in Southern African Bantu families
51. Family-based linkage disequilibrium mapping using SNP marker haplotypes: Application to a potential locus for schizophrenia at chromosome 22q11
52. Lack of association between schizophrenia and a CAG repeat polymorphism of the hSKCa3 gene in a north eastern US sample
53. Transmission test for linkage disequilibrium: The insulin gene region and insulin-dependent diabetes mellitus (IDDM)
54. Association of dopamine D3-receptor gene variants with neuroleptic induced akathisia in schizophrenic patients: A generalization of Steen's study on DRD3 and tardive dyskinesia
55. Manganese superoxide dismutase gene polymorphism and schizophrenia: Relation to tardive dyskinesia
56. Novel polymorphisms of the human cholecystokinin A receptor gene: An association analysis with schizophrenia
57. Dopamine D4 receptor 48-bp repeat polymorphism: No association with response to antipsychotic treatment, but association with catatonic schizophrenia
58. The CCK-A receptor gene possibly associated with positive symptoms of schizophrenia
59. Mutation and association analysis of the 5′ region of the dopamine D3 receptor gene in schizophrenia patients: Identification of the Ala38Thr polymorphism and suggested association between DRD3 haplotypes and schizophrenia
60. Association analysis of the 5-HT5A gene in depression, psychosis and antipsychotic response
61. The high affinity neurotensin receptor gene (NTSR1): Comparative sequencing and association studies in schizophrenia
62. DRD3 and DAT1 genes in schizophrenia: An association study
63. CYP2D6 genotyping in patients on psychoactive drug therapy
64. Brain derived neurotrophic factor (BDNF) gene variants association with age at onset and therapeutic response in schizophrenia
65. Association between Taq1 a dopamine D2 receptor polymorphism and psychopathology of schizophrenia in Japanese patients
66. Searching for genetic determinants in the new millennium
67. Single nucleotide polymorphisms and the future of genetic epidemiology
68. Genomewide genetic linkage analysis confirms the presence of susceptibility loci for schizophrenia, on chromosomes 1q32.2, 5q33.2, and 8p21-22 and provides support for linkage to schizophrenia, on chromosomes 11q23.3-24 and 20q12.1-11.23
69. hKCa3/KCNN3 potassium channel gene: Association of longer CAG repeats with schizophrenia in Israeli Ashkenazi Jews, expression in human tissues and localization to chromosome 1q21
70. Evidence for anticipation in schizophrenia
71. Isolation of a novel potassium channel gene hSKCa3 containing a polymorphic CAG repeat: A candidate for schizophrenia and bipolar disorder?
72. Association between hSKCa3 and schizophrenia not confirmed by transmission disequilibrium test in 193 offspring/parents trios
73. Association analysis of CAG repeats at the KCNN3 locus in Indian patients with bipolar disorder and schizophrenia
74. Further support for an association between a polymorphic CAG repeat in the hKCa3 gene and schizophrenia
75. Genetic association study of a polymorphic CAG repeats array of calcium-activated potassium channel (KCNN3) gene and schizophrenia among the Chinese population from Taiwan
76. No evidence for involvement of KCNN3 (hSKCa3) potassium channel gene in familial and isolated cases of schizophrenia
77. Candidate-gene association studies of schizophrenia
78. An international two-stage genome-wide search for schizophrenia susceptibility genes
79. Evidence for a chromosome 2p13-14 schizophrenia susceptibility locus in families from Palau, Micronesia
80. Genome scan of European-American schizophrenia pedigrees: Results of the NIMH Genetics Initiative and Millennium Consortium
81. Genome scan for schizophrenia genes: A detailed report in an Irish cohort
82. Multicenter linkage study of schizophrenia candidate regions on chromosomes 5q, 6q, 10p, and 13q: Schizophrenia linkage collaborative group III
83. Linkage analysis of putative schizophrenia gene candidate regions on chromosomes 3p, 5q, 6p, 8p, 20p and 22q in a population-based sampled Finnish family set
84. Genome-wide study of an extended Finnish schizophrenia study sample
85. Evidence of a locus for schizophrenia and related disorders on the short arm of chromosome 5 in a large pedigree
86. A potential vulnerability locus for schizophrenia on chromosome 6p24-22: Evidence for genetic heterogeneity
87. Chromosome 6 workshop report
88. Linkage and associated studies of schizophrenia
89. Genome scan for susceptibility loci for schizophrenia
90. A genome-wide autosomal screen for schizophrenia susceptibility loci in 71 families with affected siblings: Support for loci on chromosome 10p and 6
91. A genomewide screen for schizophrenia genes in an isolated Finnish subpopulation, suggesting multiple susceptibility loci
92. Second stage of a genome scan of schizophrenia: Study of five positive regions in an expanded sample
93. Use of a quantitative trait to map a locus associated with severity of positive symptoms in familial schizophrenia to chromosome 6p
94. Eye tracking dysfunction is a putative phenotypic susceptibility marker of schizophrenia and maps to a locus on chromosome 6p in families with multiple occurrence of the disease
95. No evidence of linkage disequilibrium between a CAG repeat in the SCA1 gene and schizophrenia in Caucasian and Chinese schizophrenic subjects
96. NOTCH4 gene polymorphism and susceptibility to schizophrenia and schizoaffective disorder
97. Association between - G308A tumor necrosis factor alpha gene polymorphism and schizophrenia
98. Schizophrenia: A genome scan targets chromosomes 3p and 8p as potential sites of susceptibility genes
99. Evidence for a schizophrenia vulnerability locus on chromosome 8p in the Irish Study of High-Density Schizophrenia Families
100. Schizophrenia susceptibility loci on chromosomes 13q32 and 8p21
101. Genetic heterogeneity in schizophrenia: Stratification of genome scan data using co-segregating related phenotypes
102. Clinical features of schizophrenia and linkage to chromosomes 5q, 6p, 8p, and 10p in the Irish Study of High-Density Schizophrenia Families
103. Linkage of familial schizophrenia to chromosome 13q32
104. A schizophrenia locus may be located in region 10p15-p11
105. Transmission ratio distortion in females on chromosome 10p11-p15
106. Suggestive linkage of chromosome 10p to schizophrenia is not due to transmission ratio distortion
107. Schizophrenia and smoking: An epidemiological survey in a state hospital
108. Further investigation of a chromosome 15 locus in schizophrenia: Analysis of affected sibpairs from the NIMH Genetics Initiative
109. Linkage disequilibrium for schizophrenia at the chromosome 15q13-14 locus of the α7-nicotinic receptor subunit gene (CHRNA7)
110. Smoking and schizophrenia: Abnormal nicotinic receptor expression
111. Chromosome 22 workshop report
112. Linkage of a composite inhibitory phenotype to a chromosome 22q locus in eight Utah families
113. Linkage disequilibrium on the COMT gene in French schizophrenics and controls
114. Association analysis of a functional catechol-o-methyltransferase gene polymorphism in schizophrenic patients in Taiwan
115. Lack of evidence for association between the COMT locus and schizophrenia
116. 14-3-3 Protein eta chain gene (YWHAH) polymorphism and its genetic association with schizophrenia
117. Systematic screening of the 14-3-3 eta (eta) chain gene for polymorphic variants and case-control analysis in schizophrenia
118. Splitting schizophrenia: Periodic catatonia-susceptibility locus on chromosome 15q15
119. A missense mutation in a novel gene encoding a putative cation channel is associated with catatonic schizophrenia in a large pedigree
120. Multilocus linkage tests based on affected relative pairs
121. Generalization of the extended transmission test to two unlinked disease loci
122. Effect of chlorpromazine or haloperidol on formation of 3-methoxytyramine and normetanephrine in mouse brain
123. Stereotyped activities produced by amphetamine in several animal species and man
124. From pharmacological profiles to clinical outcomes
125. Molecular cloning and characterization of a novel dopamine receptor (D3) as a target for neuroleptics
126. A meta-analysis and transmission disequilibrium study of association between the dopamine D3 receptor gene and schizophrenia
127. Meta-analysis of DRD3 gene and schizophrenia: Ethnic heterogeneity and significant association in Caucasians
128. A cluster of single nucleotide polymorphisms in the 5′-leader of the human dopamine D3 receptor gene (DRD3) and its relationship to schizophrenia
129. Dopamine D3-receptor gene variant and susceptibility to tardive dyskinesia in schizophrenic patients
130. Genotypic association between the dopamine D3 receptor and tardive dyskinesia in chronic schizophrenia
131. Dopamine D3 receptor variant and tardive dyskinesia
132. Ser9Gly dopamine D3 receptor polymorphism and spontaneous dyskinesia in never-medicated schizophrenic patients
133. Polymorphisms in dopamine receptors: What do they tell us?
134. No linkage or linkage disequilibrium between brain-derived neurotrophic factor (BDNF) dinucleotide repeat polymorphism and schizophrenia in Irish families
135. Pharmacogenetics and the serotonin system: Initial studies and future directions
136. Meta-analysis of association between the 5-HT2a receptor T102C polymorphism and schizophrenia
137. Association between schizophrenia and T102C polymorphism of the 5-hydroxytryptamine type 2a-receptor gene
138. A family based association study of T102C polymorphism in 5HT2A and schizophrenia plus identification of new polymorphisms in the promoter
139. Schizophrenia and the serotonin-2A receptor promoter polymorphism
140. No correlation between A(-1438)G polymorphism in 5-HT2A receptor gene promoter and the density of frontal cortical 5-HT2A receptors in schizophrenia
141. Polymorphic imprinting of the serotonin-2A (5-HT2A) receptor gene in human adult brain
142. Pharmacogenetics of schizophrenia
143. A functional polymorphism of the cytochrome P450 1A2 (CYP1A2) gene: Association with tardive dyskinesia in schizophrenia
144. The common PPARgamma Pro 12A1a polymorphism is associated with decreased risk of type 2 diabetes
145. Loci on chromosomes 2 (NIDDM1) and 15 interact to increase susceptibility to diabetes in Mexican Americans
146. Genetic variation in the gene encoding calpain-10 is associated with type 2 diabetes mellitus